Agilent Technologies Inc.A

Health Care · Pharmaceuticals, Biotechnology & Life Sciences · NYSE · United States · agilent.com

Agilent Technologies is a global provider of analytical instruments, software, services, and consumables for life sciences, diagnostics, and applied chemical markets. Its products include chromatography, mass spectrometry, genomics, and laboratory automation solutions used in pharmaceutical, environmental, food safety, and clinical research applications. Headquartered in Santa Clara, California, the company was spun off from Hewlett-Packard in 1999.

Key ratios

Operating cash flow growth

7.6%TTM

2025 -11.0%2024 -1.2%2023 35.1%

EPS growth

18.4%TTM

2025 3.2%2024 5.7%2023 0.2%

FCF / Sales

17.2%TTM

2025 16.6%2024 21.1%2023 21.6%

Net margin

19.5%TTM

2025 18.8%2024 19.8%2023 18.2%

ROA

8.6%TTM

2025 8.5%2024 8.9%2023 8.5%

ROE

21.0%TTM

2025 20.6%2024 22.0%2023 22.2%

Revenue growth

8.6%TTM

2025 6.7%2024 -4.7%2023 -0.2%

Recent news

Agilent Completes Acquisition of Biocare Medical 2026-06-25 · BioSpace Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results 2026-05-27 · BusinessWire

Track A in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer